Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
174.94
+0.53 (0.31%)
Jun 4, 2025, 1:18 PM - Market open
Ascendis Pharma Analyst Ratings
Total Analysts
16
Consensus Rating
Strong Buy
Price Target
$214.50
Upside
+22.62%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Maintains $196 → $201 | Strong Buy | Maintains | $196 → $201 | +14.90% | Jun 3, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $200 | Buy | Reiterates | $200 | +14.33% | May 12, 2025 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $180 → $250 | Hold → Buy | Upgrades | $180 → $250 | +42.91% | May 5, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $205 → $210 | Buy | Maintains | $205 → $210 | +20.04% | May 2, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $200 → $245 | Buy | Maintains | $200 → $245 | +40.05% | May 2, 2025 |
| Wedbush | Wedbush | Buy Maintains $181 → $212 | Buy | Maintains | $181 → $212 | +21.19% | May 2, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $260 → $280 | Buy | Maintains | $260 → $280 | +60.06% | May 2, 2025 |
| RBC Capital | RBC Capital | Buy Initiates $205 | Buy | Initiates | $205 | +17.19% | Apr 16, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $168 → $200 | Buy | Maintains | $168 → $200 | +14.33% | Mar 18, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $170 → $200 | Buy | Maintains | $170 → $200 | +14.33% | Feb 25, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $220 → $260 | Buy | Maintains | $220 → $260 | +48.63% | Feb 18, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $200 → $225 | Strong Buy | Maintains | $200 → $225 | +28.62% | Feb 13, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $167 → $168 | Buy | Maintains | $167 → $168 | -3.96% | Feb 13, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $170 | Buy | Reiterates | $170 | -2.82% | Feb 11, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $165 → $167 | Buy | Maintains | $165 → $167 | -4.54% | Jan 29, 2025 |
| UBS | UBS | Strong Buy Initiates $196 | Strong Buy | Initiates | $196 | +12.04% | Jan 7, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.